Hillhurst Biopharmaceuticals

PharmaceuticalsSeedSan Diego, UShillhurstbio.com

Latest round

Seed

Last raised

Sep 2023

Total raised

$1.8M

Investors

1

About Hillhurst Biopharmaceuticals

Based in California, US, and founded in 2021 by Chief Executive Officer Andrew Gomperts and Chairman Edward Gomperts, Hillhurst Biopharmaceuticals, Inc. operates as a biopharmaceutical company providing therapeutic gases to treat patients with sickle cell disease. Fox Foundation and the Farmer Family Foundation. Hillhurst Biopharmaceuticals, Inc. develops a Glass technology platform addresses the limitations of inhaled gases, ensuring accurate dosing without the risks associated with traditional inhalation methods. The company creates liquid drug products containing concentrations of the targeted therapeutic gas. In addition, the firm provides a variety of programs such as HBI-002, HBI-137, HBI-201, and others. Hillhurst Biopharmaceuticals, Inc. offers therapies and treatment for a variety of diseases such as sickle cell disease, parkinson’s disease, cardio protection from doxorubicin toxicity, kidney transplant, and acute pain.

Who invested in Hillhurst Biopharmaceuticals

1 investor across 1 round

See all investors in Hillhurst Biopharmaceuticals

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Sep 11, 2023

    Amount

    $1.8M

    Investors

    Locked

Questions about Hillhurst Biopharmaceuticals

Who invested in Hillhurst Biopharmaceuticals?

Hillhurst Biopharmaceuticals has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Hillhurst Biopharmaceuticals raised?

Hillhurst Biopharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Hillhurst Biopharmaceuticals last raise money?

Hillhurst Biopharmaceuticals's most recent round on record is a Seed, in Sep 2023.

What does Hillhurst Biopharmaceuticals do?

Based in California, US, and founded in 2021 by Chief Executive Officer Andrew Gomperts and Chairman Edward Gomperts, Hillhurst Biopharmaceuticals, Inc.

Where is Hillhurst Biopharmaceuticals headquartered?

Hillhurst Biopharmaceuticals is headquartered in San Diego, US.

Which VCs invest in companies like Hillhurst Biopharmaceuticals?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Hillhurst Biopharmaceuticals's stage. Their profiles are linked below.

Raising like Hillhurst Biopharmaceuticals? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.